Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, G T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G T
Topic Collections
Right arrowRelevant Article
Gut 2002;51:6-7
© 2002 by Gut


COMMENTARY

Colorectal cancer

A long hard look at Dukes' B

G T Williams

Department of Pathology, University of Wales College of Medicine, Cardiff, CF14 4XN; williamsgt@cf.ac.uk


Identification of prognostic pathological factors in Dukes' B colon cancer


Keywords: colon cancer; prognostic parameters; Dukes' stage B; venous spread; prognosis

Carcinoma of the colon is somewhat of a Cinderella among colorectal cancers, and during the last few years its ugly sister, carcinoma of the rectum, has hogged the limelight. This has been largely due to the (deserved) attention that has been paid to reducing local recurrence in rectal cancer through better preoperative imaging, surgical technique, and adjuvant chemoradiotherapy. However, cancer of the colon remains a highly lethal tumour. There is little controversy that it is best treated initially by surgical resection, that patients with completely resected Dukes' A tumours of usual histological type require no more treatment, and that patients found to have Dukes' C tumours after histological examination of the resection specimen should be offered adjuvant chemotherapy.1 For the 40% or so of colonic cancers that are Dukes' B, however, there is great uncertainty surrounding the place of such chemotherapy, as has been highlighted in the recently . . . [Full text of this article]


Relevant Article

Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer
V C Petersen, K J Baxter, S B Love, and N A Shepherd
Gut 2002 51: 65-69. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
GutHome page
K E Nnoaham and C Lines
Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme
Gut, September 1, 2008; 57(9): 1238 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. C. Lin, C. Neevel, P.-S. Chen, G. Suh, and J. H. Chen
Slowing of intestinal transit by fat or peptide YY depends on {beta}-adrenergic pathway
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1310 - G1316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology